SUBSTITUTED 1-AZA-2-IMINO-HETEROCYCLES AND THEIR USE AS ACTIVATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
申请人:Daiichi Suntory Pharma Co., Ltd.
公开号:EP1185521B1
公开(公告)日:2004-10-06
[EN] SUBSTITUTED 1-AZA-2-IMINO-HETEROCYCLES AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTORS ACTIVATORS<br/>[FR] 1-AZA-2-IMINO-HÉTÉROCYCLES SUBSTITUÉS ET LEUR UTILISATION COMME ACTIVATEURS DE RÉCEPTEURS NICOTINIQUES D'ACÉTYLCHOLINE
申请人:SUNTORY LTD
公开号:WO2001081326A1
公开(公告)日:2001-11-01
There is provided heterocyclic compounds of the following formula (I): in which, A is optionally substituted alkyl group, optionally substituted aryl group or optionally substituted heterocyclic group; B?1 and B2¿ are, hydrogen atom, alkyl group or hydroxyl group; or combined together to represent carbonyl group; X is oxygen atom, sulfur atom, carbon atom or nitrogen atom; dotted line shows either presence or absence of bond; n is integer of 1 or 2; and the group -X-Y- represents optionally substituted alkylene or cyclic alkenylene bond; or a pharmaceutically acceptable salt thereof. These compounds have good affinity for α4β2 nicotinic acetylcholine receptors and activate the same to thereby exert a preventive or therapeutic effect on cerebral dysfunction.11
Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators
申请人:——
公开号:US20030134848A1
公开(公告)日:2003-07-17
There is provided heterocyclic compounds of the following formula (I):
1
in which,
A is optionally substituted alkyl group, optionally substituted aryl group or optionally substituted heterocyclic group;
B
1
and B
2
are, hydrogen atom, alkyl group or hydroxyl group; or combined together to represent carbonyl group;
X is oxygen atom, sulfur atom, carbon atom or nitrogen atom;
dotted line shows either presence or absence of bond;
n is integer of 1 or 2; and
the group —X—Y— represents optionally substituted alkylene or cyclic alkenylene bond;
or a pharmaceutically acceptable salt thereof.
These compounds have good affinity for &agr;4&bgr;2 nicotinic acetylcholine receptors and activate the same to thereby exert a preventive or therapeutic effect on cerebral dysfunction.